An alternative to conventional immunosuppression: Small-molecule inhibitors of Kv 1.3 channels

Molecular Interventions

Volumn 4, Issue 5, 2004, Pages 250-254

  Damjanovich, Sándor ^a   Gáspár, Rezsó ^a   Panyi, György ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 BUTOXYPHENYL)PSORALEN; ANTIGEN; BENZAMIDE DERIVATIVE; BERGAPTEN; CALCINEURIN; CALCINEURIN INHIBITOR; CALCIUM ION; CALMODULIN; CD45 ANTIGEN; CHARYBDOTOXIN; CHEMOKINE RECEPTOR CCR7; CORREOLIDE; CYCLOSPORIN A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INOSITOL 1,4,5 TRISPHOSPHATE DERIVATIVE; KALIOTOXIN; MARGATOXIN; PHOSPHATASE; PHOSPHOLIPASE C; PI 2; PI2; POTASSIUM CHANNEL BLOCKING AGENT; PSORA 4; RUTA GRAVEOLENS EXTRACT; SHK DAP22 TOXIN; SHK TOXIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS; TRAM 34; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANTIGEN DETECTION; AUTOIMMUNITY; BINDING AFFINITY; CALCIUM TRANSPORT; CANCER; DRUG RECEPTOR BINDING; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NEPHROTOXICITY; NONHUMAN; PROTEIN FUNCTION; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KV1.3 POTASSIUM CHANNEL; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES;

EID: 7244247239     PISSN: 15340384     EISSN: None     Source Type: Journal    
DOI: 10.1124/mi.4.5.4     Document Type: Review

References (24)

1. Lewis, R.S. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 19, 497-521 (2001).
2. Rao, A., Luo, C., and Hogan, P.G. Transcription factors of the NFAT family: Regulation and function. Annu. Rev. Immunol. 15 707-747 (1997).
3. Jorgensen, K.A., Koefoed-Nielsen, RB., and Karamperis, N. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus. Scand. J. Immunol. 57, 93-98 (2003).
4. Matteson, D.R. and Deutsch, C. K channels in T lymphocytes: A patch clamp study using monoclonal antibody adhesion. Nature 307 468-471 (1984).
5. + channel in effector memory T cells as new target for MS. J. Clin. Invest 111, 1703-1713 (2003).
6. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 25, 280-289 (2004 ).
7. Panyi, G., Varga, Z., and Gáspár, R. Ion channels and lymphocyte activation. Immunol. Lett. 92, 55-66 (2004).
8. + conduction and selectivity. Science 280, 69-77 (1998).
9. + channels depolarize human T lymphocytes: Mechanism of the antiproliferative effect of charybdotoxin. Proc. Natl. Acad. Sci. U. S. A. 89, 10094-10098 (1992).
10. v1.3 inhibits immune responses in vivo. J. Immunol. 158, 5120-5128 (1997).
11. v1.3 potassium channels. Cell Immunol. 197, 99-107 (1999).
12. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 98, 13942-13947 (2001).
13. v1.3-blocking 5-phenylalkoxypsoralens: A new class of immunomodulators. Mol. Pharmacol. 65, 1364-1374 (2004).
14. v1.3-specific immunosuppressive polypeptide. J. Biol. Chem. 273, 32697-32707 (1998).
15. Viglietta, V., Kent, S.C., Orban, T, and Hafler, D.A. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 109, 895-903 (2002).
16. + effector memory cells relative to central memory cells. Blood 103, 3986-3988 (2004).
17. Wulff, H., Beeton, C., and Chandy, K.G. Potassium channels as therapeutic targets for autoimmune disorders. Curr Opin. Drug Discov. Devel. 6, 640-647 (2003).
18. + channels. Toxicon 43, 865-875 (2004).
19. v1.3 channels: The role of Glu7 and Lys24. J. Membr Biol. 179, 13-25 (2001).
20. v1.3. Biophys. J. 80, 1280-1297 (2001).
21. Schmalhofer, W.A., Bao, J., McManus, O.B. et al. Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties. Biochemistry 41, 7781-7794 (2002).
22. + channels: Synthesis and photoreactivity. J Med. Chem. 41, 4542-4549 (1998).
23. v1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc. Nad. Acad. Sci. U. S. A. 100, 2592-2597 (2003).
24. v1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc. Natl. Acad. Sci. U. S. A. 101, 1285-1290 (2004).